Skip to content

Effect of topical formulation of Cinnamon essential oil in treatment of Acne

Clinical study for the evaluation of a topical formulation of Cinnamon essential oil in treatment of Acne symptoms

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016030726938N2
Enrollment
15
Registered
2016-04-05
Start date
2016-04-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne. Acne, unspecified

Interventions

Cinnamon essential oil (maximum 1%) in a topical formulation will apply on acne, two times a day (morning and night), for 8 weeks.
Treatment - Drugs
Cinnamon essential oil (maximum 1%) in a topical formulation will apply on acne, two times a day (morning and night), for 8 weeks

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 58 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age of 20-58 years; Mild to Moderate Acne affection, without cystic acne; having at least 15 inflamed and 15 non-inflamed acne lesions on the face. Exclusion criteria: History of acute disease of patient or any type of sensitivity or allergy to the components of medication; Using topical anti-acne medications which include vitamin A, Alpha or Beta-hydroxy acids, Retin A, Antibiotics or benzoyl peroxide during 4 weeks before the beginning of intervention; Using oral antibiotics for treating acne during 1 month before the beginning of intervention; Using systemic isotretinoin or application of laser therapy, microdermabrasion and chemical peeling during 6 month before the beginning of intervention; Pregnant or Lactating women; Women who want to be pregnant in the next 6 month after the beginning of intervention; Patients who are exposed to long-term and direct sunlight or UV lamps, without skin protection, due to their occupation; Patients who do not follow the protocol of treatment.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Skin erythema. Timepoint: Before intervention, 4 weeks after the beginning of intervention and 8 weeks after the beginning of intervention. Method of measurement: Mexameter.;PH. Timepoint: Before intervention, 4 weeks after the beginning of intervention and 8 weeks after the beginning of intervention. Method of measurement: pH-meter.;Skin hydration. Timepoint: Before intervention, 4 weeks after the beginning of intervention and 8 weeks after the beginning of intervention. Method of measurement: Corneometer.;Change in sebum production. Timepoint: Before intervention, 4 weeks after the beginning of intervention and 8 weeks after the beginning of intervention. Method of measurement: Sebumeter.;Trans Epidermal Water Loss (TEWL). Timepoint: Before intervention, 4 weeks after the beginning of intervention and 8 weeks after the beginning of intervention. Method of measurement: TEWAmeter.;Skin marks. Timepoint: Before intervention, 4 weeks after the beginning of intervention and 8 weeks after the beginning of intervention. Method of measurement: Skin surface analyzer.;Acne lesion and presence of Propionibacterium acnes bacteria. Timepoint: Before intervention, 4 weeks after the beginning of intervention and 8 weeks after the beginning of intervention. Method of measurement: Visiopor.;Number of Comedones. Timepoint: Before intervention, 4 weeks after the beginning of intervention and 8 weeks after the beginning of intervention. Method of measurement: Clinical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdi Vazirian

Tehran University of Medical Sciences

Vazirian_m@tums.ac.ir+98 21 6412 1223

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026